Announcing Swoop’s Brand Refresh
By: Marcella Milliet Sciorra, Chief Marketing Officer
By: Kurt Robinson, Senior Vice President of Business Development, Swoop
Introduction
Pharmaceutical companies activate addressable TV campaigns to drive disease awareness, guide treatment options and establish their brand as the therapy of choice. However, patient populations are rarely considered in targeted advertising, with demographics largely driving television planning. The result is wasted spend engaging the wrong viewers, a lack of conversion and failure to elevate script lift. Swoop is changing all of this.
The Challenge
A leading US-based pharmaceutical company partnered with a leading MVPD provider to prove that serving custom targeted ads using Swoop’s segments on addressable TV would result in higher quality audiences and improved campaign results. Swoop was compared and tested against other data providers to understand how performance would be impacted.
The Solution
Swoop leveraged our proprietary health-centered real world data (RWD) that includes over 300 million de-identified patient journeys, spanning more than ten-years. Using this RWD and artificial intelligence (AI), we generated a targeted, privacy-safe segment comprised of currently diagnosed patients. This high quality audience segment was executed against the MVPD provider's universe running for six weeks at a twice-weekly frequency.
The Outcome
By partnering with Swoop to create a custom segment of targeted patients, the pharmaceutical company achieved impactful lift within three months following campaign launch. The results of the addressable campaign included increased audience quality (AQ) metrics, including 1.8x more patients, a 20% increase in HCP visits, a 34% increase in patient-driven diagnostic screening, and 24% lift in brand conversion. As Swoop’s segments are based on actual patient data, they can be utilized to reach patients nationwide, regardless of market or demographic. Data partners matter – by working with a company with better quality RWD to develop higher AQ segments, patients were motivated to convert, resulting in significant increased impact.
About the Author
Kurt Robinson
Senior Vice President of Business Development
With more than 15 years of experience in both media buying and media sales, Kurt brings a unique perspective to healthcare marketing. He is responsible for overseeing Swoop’s television partner relationships and enhancing client campaign strategies across activation channels, driving optimal brand outcomes. Kurt holds a degree in business and psychology from Ohio University.